Humoral immune activation in amyotrophic lateral sclerosis patients

被引:9
|
作者
Rentzos, Michael [1 ]
Evangelopoulos, Maria Eleftheria [1 ]
Sereti, Eleni [2 ]
Zouvelou, Vassiliki [1 ]
Marmara, Styliani [2 ]
Alexakis, Theodoros [1 ]
Evdokimidis, Ioannis [1 ]
机构
[1] Athens Natl Univ, Aeginit Hosp, Sch Med, Dept Neurol, Athens, Greece
[2] Alexandra Hosp, Immunol Dept, Athens, Greece
关键词
IgM; IgG; IgA; amyotrophic lateral sclerosis; humoral immune activation;
D O I
10.4081/ni.2013.e3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is evidence that immunological factors may involved in the pathogenetic mechanisms of amyotrophic lateral sclerosis (ALS). Few studies to date have explored the status of the humoral immune response in patients with ALS. We examined the presence of humoral immune activation in ALS patients, serum immunoglobulins (IgG, IgA and IgM) levels were measured in 36 patients with ALS and 35 normal controls. Serum IgG, IgM and IgA levels were not significantly different in our ALS patients compared with the control group (P= ns). No correlations of serum IgG, IgM and IgA concentrations with duration, severity of the disease or the clinical form of onset (bulbar or spinal) were found in our ALS patients. Our results do not suggest a humoral immune activation in ALS patients. This does not exclude that immunological mechanisms may be involved in ALS pathogenesis.
引用
收藏
页码:8 / 9
页数:2
相关论文
共 50 条
  • [41] Assessment and nutrition education in patients with amyotrophic lateral sclerosis
    Almeida, Claudinea S.
    Stanich, Patricia
    Salvioni, Cristina C. S.
    Diccini, Solange
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (11) : 902 - 908
  • [42] Alterations in the Masticatory System in Patients with Amyotrophic Lateral Sclerosis
    Riera-Punet, Nina
    Martinez-Gomis, Jordi
    Paipa, Andres
    Povedano, Monica
    Peraire, Maria
    JOURNAL OF ORAL & FACIAL PAIN AND HEADACHE, 2018, 32 (01) : 84 - 90
  • [43] Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation
    Rolfes, Leoni
    Schulte-Mecklenbeck, Andreas
    Schreiber, Stefanie
    Vielhaber, Stefan
    Herty, Michael
    Marten, Anika
    Pfeuffer, Steffen
    Ruck, Tobias
    Wiendl, Heinz
    Gross, Catharina C.
    Meuth, Sven G.
    Boentert, Matthias
    Pawlitzki, Marc
    BRAIN COMMUNICATIONS, 2021, 3 (03)
  • [44] Creatine kinase activity in amyotrophic lateral sclerosis patients
    J. Iłżecka
    Z. Stelmasiak
    Neurological Sciences, 2003, 24 : 286 - 287
  • [45] Creatine kinase activity in amyotrophic lateral sclerosis patients
    Ilzecka, J
    Stelmasiak, Z
    NEUROLOGICAL SCIENCES, 2003, 24 (04) : 286 - 287
  • [46] EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis
    Ilzecka, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2011, 124 (06): : 424 - 428
  • [47] Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis
    Caplliure-Llopis, Jordi
    Escriva, Dolores
    Benlloch, Maria
    de la Rubia Orti, Jose Enrique
    Estrela, Jose Maria
    Barrios, Carlos
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [48] Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis
    Desport, JC
    Preux, PM
    Magy, L
    Boirie, Y
    Vallat, JM
    Beaufrère, B
    Couratier, P
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2001, 74 (03) : 328 - 334
  • [49] The course of the terminal phase in patients with amyotrophic lateral sclerosis
    Neudert, C
    Oliver, D
    Wasner, M
    Borasio, GD
    JOURNAL OF NEUROLOGY, 2001, 248 (07) : 612 - 616
  • [50] Assistive Communication Application for Amyotrophic Lateral Sclerosis Patients
    Shravani, T.
    Sai, Ramya
    Shree, M. Vani
    Amudha, J.
    Jyotsna, C.
    COMPUTATIONAL VISION AND BIO-INSPIRED COMPUTING, 2020, 1108 : 1397 - 1408